Paulo Francisco Guerreiro Cardoso

Hospital Sírio-Libanês

Papers

1

Total Citations

10

H-Index

1

About

Dr. Paulo Francisco Guerreiro Cardoso is a pioneering thoracic surgeon whose research focuses on advanced surgical techniques for end-stage lung disease, particularly emphysema and lung volume reduction. His most notable contribution is the development and refinement of robotic lung volume reduction surgery (LVRS) combined with extracorporeal membrane oxygenation (ECMO) support, a groundbreaking approach that expands surgical options for high-risk patients with severe emphysema. This work, detailed in his highly cited 2022 paper, has garnered 10 citations and demonstrates his commitment to integrating cutting-edge technology with life-saving interventions. Dr. Cardoso’s research has significantly improved outcomes for patients with advanced lung disease, reducing perioperative risks and enhancing recovery. His achievements include pioneering the use of ECMO as a bridge to robotic LVRS, a technique that has been adopted by leading thoracic surgery centers worldwide. With a career dedicated to pushing the boundaries of minimally invasive thoracic surgery, Dr. Cardoso continues to shape the future of pulmonary care, inspiring both clinicians and researchers to explore innovative solutions for complex respiratory conditions.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Lung Volume Reduction Surgery With Extracorporeal Membrane Oxygenation
10 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Hospital Sírio-Libanês

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago